Table 1.
Baseline characteristics.
| N=15 (%) | ||
|---|---|---|
| Age | Median | 78 (38,85) |
| Gender | Male | 4 (26.7%) |
| Female | 11 (73.3%) | |
| ECOG | 2 | 9 (60%) |
| 3 | 6 (40%) | |
| Recurrence pattern | Local or regional recurrence only | 14 (93.3%) |
| Distant metastasis only | 1 (6.7%) | |
| PD-L1 CPS | <1 | 1 (6.7%) |
| 20>CPS≥1 | 10 (66.7%) | |
| ≥20 | 4 (26.8%) | |
| PD-L1 TPS | <1% | 4 (26.8%) |
| ≥1% | 11 (73.3%) | |
| Treatment cycle | Median | 7 (2-22) |
| Outcome | DCR PR | 6 (40%) |
| SD | 6 (40%) | |
| PD | 3 (20%) | |
| State | Alive | 3 (20%) |
| Death | 12 (80%) | |
| Cause of death | Tumor progression | 8 (53.3%) |
| Pulmonary infection | 2 (13.3%) | |
| Pulmonary infection + Hypokalemia | 1 (6.7%) | |
| Intracranial infection | 1 (6.7%) |
ECOG, Eastern Cooperative Oncology Group; PR: Partial Response; SD: Stable Disease; PD: Progressive Disease; ORR: Objective Response Rate; DCR: Disease control rate; NA, not applicable;.